Show
Sort by
-
- Conference Paper
- C3
- open access
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
Familial hemophagocytic lymphohistiocytosis type 3 presenting as neonatal cholestasis and splenomegaly
-
Brachytherapy for pediatric patients at Gustave Roussy Cancer Campus : a model of international cooperation for highly specialized treatments
-
The TEARDRoP (Team early drug development in Paediatric oncology) consortium : to help Research find its way to improved treatments for children with cancer
-
- Journal Article
- A1
- open access
Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy
-
- Journal Article
- A1
- open access
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening : an international, multicentre, retrospective cohort study
-
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
- Journal Article
- A1
- open access
Targeted therapy in juvenile myelomonocytic leukemia : where are we now?
-
- Journal Article
- A2
- open access
Practice guidelines for the therapeutic drug monitoring of asparaginase in acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia in the ELIANA trial